According to Evofem Biosciences 's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 0.0422377. At the end of 2023 the company had a P/S ratio of 0.0377.
Year | P/S ratio | Change |
---|---|---|
2023 | 0.0377 | -88.4% |
2022 | 0.3248 | -95.61% |
2021 | 7.40 | -98.31% |
2020 | 439 | |
2019 | N/A | |
2018 | N/A | |
2017 | N/A | |
2016 | N/A | |
2015 | N/A | |
2014 | N/A |
Company | P/S ratio | P/S ratio differencediff. | Country |
---|---|---|---|
OPKO Health
OPK | 1.02 | 2,307.90% | ๐บ๐ธ USA |
Onconova Therapeutics ONTX | 92.5 | 218,895.35% | ๐บ๐ธ USA |